Wesper Revolutionizes GLP-1 Sleep Apnea Screening and Enables Personalized Treatment | Newswise

Wesper Revolutionizes GLP-1 Sleep Apnea Screening and Enables Personalized Treatment | Newswise

Newswise — NEW YORK, Feb. 11, 2025 /PRNewswire/ — Wesper, a leader in advanced home sleep apnea testing (HSAT), is transforming how obesity and sleep apnea are managed by integrating groundbreaking biometric sleep data with metabolic health innovations. Following the FDA approval of GLP-1 receptor agonists for sleep apnea treatment, Wesper is working with hospitals and physicians to bridge the gap between obesity, diabetes, GLP-1 medications,…

Read More